People's United Financial’s Myriad Genetics MYGN Stock Holding History

People's United Financial’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-29,653	Closed	-$807K	–	692
2019 Q4	$807K	Buy	29,653 +110	+0.4%	+$3.03K	0.02%	405
2019 Q3	$846K	Buy	+29,543	New	+$861K	0.02%	400
2018 Q4	–	Sell	-5,275	Closed	-$243K	–	753
2018 Q3	$243K	Buy	+5,275	New	+$235K	0.01%	668

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

People's United Financial's MYGN Position: Q1 2020 in Review

People's United Financial sold out of Myriad Genetics (MYGN) in Q1 2020, closing a stake of 29,653 shares — an estimated $807K sold.

People's United Financial first reported a position in MYGN in Q3 2018 and held it in 3 quarters. The position peaked at $846K in Q3 2019. 190 funds tracked by Wall St. Rank hold MYGN as of Q1 2020.

People's United Financial reported no remaining Myriad Genetics position as of Q1 2020 after selling out during the quarter.
People's United Financial sold 29,653 Myriad Genetics shares in Q1 2020, an estimated $807K.
People's United Financial first reported a position in Myriad Genetics in Q3 2018 and held it in 3 quarters.
People's United Financial's Myriad Genetics position peaked at $846K in Q3 2019.
190 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2020.

Based on People's United Financial's 13F filing for Q1 2020, filed 12 May 2020.